Regulatory Compliance Videos

  1. How To Easily And Quickly Monitor Cleanrooms 5/6/2024

    Discover a portable particle counter for quick and easy cleanroom monitoring that features automated alarms and reporting to help you ensure compliance.

  2. How To Do Quick, Easy Cleanroom Classification 5/6/2024

    Classification plays a vital role in cleanroom certification and qualification. Discover a particle counter that simplifies testing for adherence to ISO 14644-1, EU GMP Annex 1, or China GMP standards.

  3. Process Liquids And Buffers Offering 5/2/2024

    Whether you are a researcher, scientist, or industry professional, this video will provide valuable insights into our large volume liquids manufacturing capabilities.

  4. Gain Support For Your Regulatory Submission Process 3/27/2024

    Join us in this video as we delve into invaluable tips, cutting-edge tools, and unwavering support that Cytiva offers to facilitate your documentation progress.

  5. Cell Therapy Process Development Made Easy 3/27/2024

    Explore how Fast Trak™ process development services offered by Cytiva can guide you through achieving GMP compliance in your cell therapy manufacturing process.

  6. Challenges Associated With Building New Isolator Technology 3/26/2024

    Paula Rizo, Germfree’s Mechanical Engineering Lead for Equipment, dives deeper into our collaboration with AST and how this isolator technology will transform the way pharmaceutical companies approach aseptic processing.

  7. Single-Use Strategies For Uninterrupted Microbial Monitoring 2/22/2024

    Watch as Emad Albarouki, a microbiology and sterility assurance specialist at Particle Measuring Systems, discusses the best practices for using BioCapt® Single-Use in continuous microbial active air monitoring.

  8. What Indications Can, And Will, mRNA Therapeutics Address? 12/5/2023

    During our Bioprocess Online Live event, mRNA Update: Beyond Prophylactic Vaccines, we asked an audience of several hundred biopharma professionals what indications they’re addressing in mRNA therapeutic development. Here, our panelists address their responses and offer final thoughts on unfolding mRNA regulatory frameworks.

  9. Safety & CQAs: Do mRNA Therapeutic Regulators Know What They Want? 12/5/2023

    In this segment, Combined Therapeutics CSO Thomas Van Cott, Ph.D. and Omega Therapeutics Executive Director, Process Development and Analytical Sciences Jeff Atkinson, Ph.D. address regulators’ likely safety and CQA concerns as well as audience questions regarding variable and changing RNA constructs.

  10. US GMP (21 CFR 820) Manufactured Oligos For Preclinical Research 10/18/2023

    Learn why Custom cGMP Oligos should be considered to ensure oligo products meet the strict standards of MDx, LDTs, and preclinical research.